Home> Products> sustained manner

{ "products": [ { "_id": "6a05af2f5973eae52aa766f8", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "gabapentin sustained release tablets 450 mg", "description": "Introduction to Gabapentin Sustained Release Tablets 450 mg\n\nGabapentin Sustained Release Tablets 450 mg are widely prescribed for the management of nerve-related pain and certain neurological conditions. These tablets are formulated with sustained-release technology, which allows the medicine to release gradually in the body over time. This helps maintain a stable therapeutic effect and reduces the need for frequent dosing.\n\nPatients suffering from neuropathic pain, diabetic nerve pain, post-herpetic neuralgia, or other nerve disorders often look for long-lasting and effective relief. Gabapentin Sustained Release Tablets 450 mg are designed to provide extended support throughout the day while improving patient comfort and compliance.\n\nThe sustained-release formulation is especially beneficial for individuals who require continuous symptom management without experiencing sudden fluctuations in medicine levels. Healthcare professionals frequently recommend this dosage because of its balanced effectiveness and convenient administration.\n\nWhat Are Gabapentin Sustained Release Tablets 450 mg?\n\nGabapentin Sustained Release Tablets 450 mg contain gabapentin as the active pharmaceutical ingredient. Gabapentin belongs to a class of medicines known as anticonvulsants or nerve pain modulators. It is commonly used to control abnormal nerve signals in the body.\n\nUnlike immediate-release formulations, sustained-release tablets slowly release the medication over several hours. This controlled release mechanism helps in maintaining prolonged relief from nerve pain and discomfort.\n\nThese tablets are often prescribed for:\n\nNeuropathic pain\nDiabetic neuropathy\nPost-herpetic neuralgia\nFibromyalgia-related nerve discomfort\nCertain seizure disorders\nChronic nerve-related pain conditions\n\nBecause nerve pain can significantly affect daily life, sleep quality, and mobility, many patients prefer sustained-release formulations for their consistent action and reduced dosing frequency.\n\nHow Gabapentin Sustained Release Tablets 450 mg Work\n\nGabapentin works by affecting the transmission of nerve signals in the central nervous system. In nerve pain conditions, damaged nerves may send abnormal pain signals to the brain. Gabapentin helps calm these overactive nerve impulses and reduces the sensation of pain, burning, tingling, or numbness.\n\nThe sustained-release technology ensures that the medicine is gradually absorbed into the bloodstream. This offers several advantages:\n\nLonger-lasting pain relief\nReduced fluctuations in drug levels\nBetter nighttime symptom control\nImproved patient adherence\nLower frequency of dosing\n\nPatients with chronic neuropathic conditions often benefit from the steady therapeutic action provided by Gabapentin Sustained Release Tablets 450 mg.\n\nUses of Gabapentin Sustained Release Tablets 450 mg\n\nGabapentin Sustained Release Tablets 450 mg are commonly used in the treatment and management of multiple conditions related to nerve dysfunction.\n\n1. Neuropathic Pain\n\nNeuropathic pain develops due to nerve damage or malfunction. Patients may experience sharp pain, burning sensations, tingling, or electric shock-like discomfort. Gabapentin helps reduce these symptoms effectively.\n\n2. Diabetic Neuropathy\n\nPeople with diabetes may develop nerve damage over time, especially in the legs and feet. Gabapentin Sustained Release Tablets 450 mg help control pain, numbness, and discomfort associated with diabetic neuropathy.\n\n3. Post-Herpetic Neuralgia\n\nAfter shingles infection, some patients continue to experience persistent nerve pain. Gabapentin is commonly prescribed to manage this condition and improve quality of life.\n\n4. Partial Seizures\n\nGabapentin may also be used as an adjunct therapy in certain seizure disorders under medical supervision.\n\n5. Fibromyalgia and Chronic Pain Disorders\n\nSome healthcare professionals recommend gabapentin for chronic pain syndromes involving nerve sensitivity and persistent discomfort.\n\nBenefits of Gabapentin Sustained Release Tablets 450 mg\nLong-Lasting Relief\n\nThe sustained-release formulation provides extended symptom management throughout the day and night.\n\nImproved Patient Convenience\n\nReduced dosing frequency makes it easier for patients to follow their treatment schedule consistently.\n\nStable Therapeutic Effect\n\nThe gradual release mechanism helps maintain balanced medicine levels in the body.\n\nBetter Sleep Quality\n\nMany patients with nerve pain struggle to sleep because of discomfort. Gabapentin may help reduce nighttime pain and improve rest.\n\nEnhanced Daily Functioning\n\nBy controlling chronic nerve pain, patients can experience better mobility, comfort, and overall quality of life.\n\nReduced Sudden Drug Peaks\n\nSustained-release tablets help avoid abrupt rises and falls in medicine concentration, contributing to smoother symptom control.\n\nWho May Need Gabapentin Sustained Release Tablets 450 mg?\n\nGabapentin Sustained Release Tablets 450 mg may be recommended for:\n\nAdults with chronic nerve pain\nPatients suffering from diabetic neuropathy\nIndividuals with post-shingles nerve pain\nPatients requiring prolonged pain control\nIndividuals experiencing tingling, numbness, or burning sensations\nPatients needing supportive seizure management\n\nA healthcare professional will determine the appropriate dosage and duration depending on the patient’s condition and response to therapy.\n\nHow to Take Gabapentin Sustained Release Tablets 450 mg\n\nPatients should always follow the dosage instructions provided by their healthcare provider.\n\nGeneral administration guidelines include:\n\nSwallow the tablet whole with water\nDo not crush, chew, or break the tablet\nTake the medicine at the same time daily\nCan be taken with or without food, depending on medical advice\nAvoid missing doses for consistent symptom control\n\nThe sustained-release mechanism works properly only when the tablet is taken intact.\n\nPossible Side Effects of Gabapentin Sustained Release Tablets 450 mg\n\nLike all medicines, Gabapentin Sustained Release Tablets 450 mg may cause some side effects in certain individuals. Most side effects are mild to moderate and may decrease as the body adjusts to the medication.\n\nCommon side effects may include:\n\nDizziness\nDrowsiness\nFatigue\nSleepiness\nCoordination problems\nBlurred vision\nSwelling in hands or feet\nDry mouth\n\nPatients should seek medical attention if they experience severe allergic reactions, breathing difficulties, or unusual behavioral changes.\n\nPrecautions and Safety Information\n\nBefore taking Gabapentin Sustained Release Tablets 450 mg, patients should inform their healthcare provider about any existing medical conditions or ongoing treatments.\n\nImportant precautions include:\n\nUse cautiously in kidney disorders\nAvoid alcohol consumption during treatment\nDo not suddenly stop the medication without medical advice\nInform the doctor about pregnancy or breastfeeding\nUse caution while driving or operating machinery if dizziness occurs\n\nFollowing medical guidance helps ensure safe and effective treatment outcomes.\n\nWhy Choose Gabapentin Sustained Release Tablets 450 mg?\n\nPatients and healthcare providers often prefer Gabapentin Sustained Release Tablets 450 mg because of their reliable symptom management and patient-friendly formulation.\n\nKey reasons include:\n\nExtended-release technology\nConsistent pain management\nConvenient once or twice daily dosing\nSuitable for chronic conditions\nImproved treatment adherence\nEffective management of neuropathic symptoms\n\nThe formulation is particularly useful for patients seeking long-duration relief from persistent nerve pain.\n\nStorage Instructions\n\nProper storage helps maintain the quality and effectiveness of the medicine.\n\nStore in a cool and dry place\nKeep away from direct sunlight\nProtect from moisture\nKeep out of reach of children\nDo not use expired medication\n\nAlways check packaging instructions for specific storage recommendations.\n\nConclusion\n\nGabapentin Sustained Release Tablets 450 mg are an effective and widely trusted option for managing neuropathic pain and related neurological conditions. With sustained-release technology, these tablets provide prolonged relief, stable symptom control, and improved patient convenience.\n\nWhether used for diabetic neuropathy, post-herpetic neuralgia, chronic nerve pain, or supportive seizure therapy, Gabapentin Sustained Release Tablets 450 mg helps patients achieve better comfort and daily functioning. Their long-lasting action, convenient dosing schedule, and reliable therapeutic effect make them a preferred choice for many healthcare professionals and patients alike.", "price": 375.0, "discountamount": 112.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2421, "imageuri": "https://productimages.withfloats.com/actual/6a05af338d715b31cefe444d.jpg", "tileimageuri": "https://productimages.withfloats.com/tile/6a05af338d715b31cefe444d.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-05-14T11:17:03.427Z", "updatedon": "2026-05-14T11:17:03.427Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/gabapentin-sustained-release-tablets-450-mg/2421", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Stargab SR 450", "category": "NEUROLOGY RANGE", "tags": [ "gabapentin sustained release tablets 450 mg", "Gabapentin Sustained Release Tablets 450 mg", "Gabapentin 450 mg Neuropathic Pain Treatment Tablets", "Nerve Pain Relief Medicine Gabapentin 450 mg", "Gabapentin SR 450 mg Prescription Medicine", "Sustained Release Gabapentin Tablets 450 mg", "Gabapentin 450 mg Product Image", "Gabapentin SR 450 mg Pharmaceutical Medicine", "Gabapentin 450 mg Extended Release Tablets", "Oral Gabapentin Sustained Release Tablets" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "699bfe45e844b0fb29d2bbad", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Sitagliptin 100 Pioglitazone 15 Metformin 500", "description": "Product Name: ST GLIPTIN 3D 500\nComposition: Sitagliptin 100 mg + Pioglitazone 15 mg + Metformin 500 mg\n\nST GLIPTIN 3D 500 is a scientifically formulated triple-combination oral antidiabetic tablet designed to help manage Type 2 Diabetes Mellitus effectively. This advanced formulation combines the proven benefits of Sitagliptin, Pioglitazone, and Metformin to provide comprehensive glycemic control through three complementary mechanisms of action.\n\nThis triple therapy approach is especially beneficial for patients whose blood glucose levels are not adequately controlled with dual therapy or monotherapy. ST GLIPTIN 3D 500 is developed to address multiple metabolic defects associated with Type 2 diabetes, ensuring better long-term glucose management and improved patient outcomes.\n\nProduct Description\n\nST GLIPTIN 3D 500 is an oral antidiabetic medication that works by targeting different physiological pathways involved in glucose regulation:\n\nSitagliptin 100 mg enhances incretin hormone levels, which increase insulin release and decrease glucagon secretion in a glucose-dependent manner.\n\nPioglitazone 15 mg improves insulin sensitivity in muscle and adipose tissues, allowing the body to use insulin more effectively.\n\nMetformin 500 mg reduces hepatic glucose production and improves peripheral glucose uptake.\n\nBy combining these three well-established agents into a single tablet, ST GLIPTIN 3D 500 simplifies diabetes management while improving adherence and therapeutic efficiency.\n\nUses of ST GLIPTIN 3D 500\n\nST GLIPTIN 3D 500 is primarily indicated for:\n\nManagement of Type 2 Diabetes Mellitus\n\nImproving glycemic control in adults\n\nPatients inadequately controlled on metformin alone\n\nIndividuals requiring triple oral therapy\n\nReducing fasting and postprandial blood glucose levels\n\nSupporting long-term HbA1c reduction\n\nIt is typically prescribed alongside lifestyle modifications such as a healthy diet, regular exercise, and weight management.\n\nHow ST GLIPTIN 3D 500 Works\n\nType 2 diabetes is characterized by insulin resistance, decreased insulin secretion, and excessive hepatic glucose production. ST GLIPTIN 3D 500 addresses all three core defects:\n\nEnhances insulin secretion (Sitagliptin) – Works in a glucose-dependent manner, reducing risk of hypoglycemia.\n\nImproves insulin sensitivity (Pioglitazone) – Helps the body respond better to insulin.\n\nReduces glucose production (Metformin) – Decreases sugar release from the liver.\n\nThis comprehensive mechanism makes ST GLIPTIN 3D 500 a powerful therapeutic option for sustained glycemic control.\n\nKey Benefits of ST GLIPTIN 3D 500\n1. Triple Mechanism Advantage\n\nCombines three different classes of antidiabetic agents for broader and more effective blood sugar management.\n\n2. Improved HbA1c Reduction\n\nHelps significantly lower HbA1c levels when compared to monotherapy.\n\n3. Reduced Pill Burden\n\nThree medications in one tablet improve patient compliance and convenience.\n\n4. Better Postprandial Control\n\nHelps manage blood glucose spikes after meals.\n\n5. Insulin Sensitivity Enhancement\n\nPioglitazone improves peripheral glucose utilization.\n\n6. Lower Risk of Hypoglycemia\n\nSitagliptin works in a glucose-dependent manner, minimizing low blood sugar risk when used appropriately.\n\n7. Suitable for Long-Term Management\n\nDesigned for chronic use under medical supervision.\n\nDosage and Administration\n\nThe dosage should be taken strictly as prescribed by a healthcare professional.\n\nUsually administered once daily with meals to reduce gastrointestinal discomfort.\n\nSwallow the tablet whole with water.\n\nDo not crush or chew unless directed by a doctor.\n\nRegular monitoring of blood glucose and HbA1c levels is recommended during therapy.\n\nPossible Side Effects\n\nLike all medications, ST GLIPTIN 3D 500 may cause side effects, although not everyone experiences them.\n\nCommon Side Effects:\n\nNausea\n\nDiarrhea\n\nStomach discomfort\n\nHeadache\n\nUpper respiratory symptoms\n\nLess Common but Important:\n\nWeight gain (associated with Pioglitazone)\n\nFluid retention or edema\n\nLow blood sugar (when combined with other antidiabetic agents)\n\nVitamin B12 deficiency (long-term Metformin use)\n\nRare but Serious:\n\nLactic acidosis (rare, associated with Metformin)\n\nPancreatitis (rare, associated with Sitagliptin)\n\nLiver function abnormalities\n\nPatients should immediately consult a healthcare provider if they experience severe abdominal pain, persistent vomiting, unusual swelling, or breathing difficulties.\n\nPrecautions and Warnings\n\nNot recommended for Type 1 diabetes.\n\nUse cautiously in patients with renal impairment.\n\nLiver function monitoring may be required.\n\nAvoid excessive alcohol consumption.\n\nInform your doctor about any existing heart conditions.\n\nPregnant or breastfeeding women should use this medication only if clearly advised by a healthcare professional.\n\nStorage Instructions\n\nStore below 25°C in a dry place.\n\nKeep away from direct sunlight.\n\nKeep out of reach of children.\n\nWhy Choose ST GLIPTIN 3D 500?\n\nST GLIPTIN 3D 500 stands out as a comprehensive diabetes management solution by combining three powerful and clinically established molecules in one convenient tablet. It is particularly beneficial for patients who require intensified glycemic control without increasing pill burden.\n\nThe triple therapy model helps target multiple metabolic dysfunctions simultaneously, offering better blood glucose stability throughout the day. When used as part of a complete diabetes management plan—including diet, exercise, and routine monitoring—ST GLIPTIN 3D 500 can significantly enhance quality of life and reduce long-term complications associated with uncontrolled diabetes.\n\nConclusion\nST GLIPTIN 3D 500 (Sitagliptin 100 mg + Pioglitazone 15 mg + Metformin 500 mg) represents a modern, evidence-based approach to managing Type 2 Diabetes Mellitus. By addressing insulin resistance, impaired insulin secretion, and excessive glucose production, it provides comprehensive and sustained glycemic control.", "price": 222.0, "discountamount": 67.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2311, "imageuri": "https://productimages.withfloats.com/actual/699bfe47d849febb9bcc2d46.png", "tileimageuri": "https://productimages.withfloats.com/tile/699bfe47d849febb9bcc2d46.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-02-23T07:14:13.494Z", "updatedon": "2026-03-13T11:04:02.141Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//sitagliptin-100-pioglitazone-15-metformin-500/2311", "availableunits": -1.0, "iscodavailable": true, "isprepaidonlineavailable": true, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "ST GLIPTIN 3D 500", "category": "DIABETIC RANGE", "tags": [ "Sitagliptin 100 Pioglitazone 15 Metformin 500 tablet uses", "Sitagliptin Pioglitazone Metformin triple therapy dosage", "Sitagliptin 100 mg Pioglitazone 15 mg Metformin 500 mg benefits", "Triple combination tablet for type 2 diabetes control", "Sitagliptin Pioglitazone Metformin side effects in adults", "How to take Sitagliptin Pioglitazone Metformin tablet", "Sitagliptin Metformin Pioglitazone price in India", "Buy Sitagliptin 100 Pioglitazone 15 Metformin 500 online", "Order Sitagliptin Pioglitazone Metformin tablets", "Sitagliptin 100 Pioglitazone 15 Metformin 500 price", "Sitagliptin triple combination bulk purchase" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "68fcb453ba48b3ee8857fd47", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Sitagliptin Phosphate Monhydrate 64.25 mg, Sitagliptin 50 mg, Metformin Hydrochloride 1000 mg & Glimepirde 1 mg", "description": "ST GLIPTIN GM is a high-quality, fixed-dose combination oral antidiabetic medication containing Sitagliptin 50 mg, Metformin Hydrochloride 1000 mg, and Glimepiride 1 mg. This triple-combination therapy is specifically formulated to provide effective glycemic control in adults with type 2 diabetes mellitus (T2DM) who require multiple agents to achieve adequate blood sugar control.\nST GLIPTIN GM works through complementary mechanisms to target the core pathophysiological defects of T2DM—insulin resistance, impaired insulin secretion, and increased hepatic glucose output—making it an ideal choice for patients requiring intensified therapy.\nKey Indications:\nST GLIPTIN GM is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus when dual therapy with any two of the individual components (Sitagliptin, Metformin, or Glimepiride) does not provide adequate control.\nMechanism of Action:\nSitagliptin (50 mg):\nA Dipeptidyl Peptidase-4 (DPP-4) inhibitor that enhances the levels of active incretin hormones (GLP-1 and GIP), increasing insulin release and decreasing glucagon secretion in a glucose-dependent manner.\nMetformin Hydrochloride (1000 mg):\nA biguanide that improves insulin sensitivity by decreasing hepatic glucose production and enhancing peripheral glucose uptake.\nGlimepiride (1 mg):\nA sulfonylurea that stimulates pancreatic β-cells to secrete insulin, thereby reducing blood glucose levels.\nThe combination targets multiple metabolic pathways to provide synergistic and sustained blood glucose control.\nDosage and Administration:\nRecommended Dose:\nOne tablet daily, preferably with meals to reduce gastrointestinal side effects.\nIndividualization Required:\nDosage should be tailored based on patient response, renal function, and physician assessment.\nRenal Monitoring:\nBaseline and periodic assessment of renal function is advised, particularly due to the metformin component.\nKey Benefits of ST GLIPTIN GM 50/1000/1:\nTriple Mechanism of Action:\nTargets insulin resistance, insufficient insulin secretion, and excessive hepatic glucose production.\nEnhanced Glycemic Control:\nEffective in achieving and maintaining HbA1c targets.\nOnce-Daily Convenience:\nImproves adherence by reducing pill burden in patients requiring combination therapy.\nWeight Neutral to Modest Reduction:\nMetformin and sitagliptin components support weight neutrality.\nLow Hypoglycemia Risk:\nSitagliptin and metformin carry minimal hypoglycemia risk; however, glimepiride may increase the risk—monitor accordingly.\nSafety and Precautions:\nHypoglycemia:\nMay occur, particularly due to the glimepiride component. Educate patients on recognizing and managing low blood sugar.\nLactic Acidosis:\nA rare but serious complication of metformin. Avoid in patients with significant renal impairment or conditions predisposing to hypoxia.\nRenal Function:\nDose adjustment or discontinuation may be needed based on renal function.\nPancreatitis:\nRare reports with DPP-4 inhibitors like sitagliptin. Discontinue if suspected.\nAllergic Reactions:\nDiscontinue use if hypersensitivity reactions occur.\nPossible Side Effects:\nWhile ST GLIPTIN GM is generally well-tolerated, some patients may experience:\nNausea\nDiarrhea\nHeadache\nHypoglycemia (especially in elderly or with missed meals)\nAbdominal discomfort\nUpper respiratory tract infections\nDizziness\nFlatulence\nIf any side effects persist or worsen, seek immediate medical advice.\nStorage Instructions:\nStore at a temperature below 30°C.\nProtect from moisture and direct sunlight.\nKeep out of reach of children.\nWhy Choose ST GLIPTIN GM 50/1000/1?\nST GLIPTIN GM provides a powerful and synergistic combination of three well-established antidiabetic agents in a single, convenient daily dose. It offers a comprehensive approach to managing type 2 diabetes by addressing multiple metabolic abnormalities with a focus on safety, efficacy, and patient compliance. Manufactured under stringent GMP-certified conditions, ST GLIPTIN GM ensures quality, reliability, and therapeutic confidence for both patients and prescribers.", "price": 285.0, "discountamount": 86.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2188, "imageuri": "https://productimages.withfloats.com/actual/68fcb456f31288eaa96accfa.png", "tileimageuri": "https://productimages.withfloats.com/tile/68fcb456f31288eaa96accfa.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-10-25T11:28:19.425Z", "updatedon": "2026-03-13T10:40:20.1Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//sitagliptin-phosphate-monhydrate-64-25-mg-sitagliptin-50-mg-metformin-hydrochloride-1000-mg-glimepirde-1-mg/2188", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "ST GLIPTIN GM 50+1000+1", "category": "DIABETIC RANGE", "tags": [ "Sitagliptin 50 mg", "Sitagliptin 50 mg, Metformin Hydrochloride 1000 mg, and Glimepiride 1 mg", "type 2 diabetes mellitus (T2DM)", "blood sugar control" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "666ae115cee93a1bbc383b92", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "QT-PINE SR 200 ", "description": "QT-PINE SR 200 \nQuetiapine Prolonged Release 200mg\nIntroduction:\nQT-PINE SR 200 is a medication containing Quetiapine in a prolonged-release formulation, designed to provide sustained therapeutic effects for individuals with psychiatric disorders. Quetiapine is an atypical antipsychotic known for its efficacy in managing schizophrenia, bipolar disorder, major depressive disorder (MDD), and other psychiatric conditions.\nKey Features and Benefits:\nExtended Release Formulation:\nQT-PINE SR 200 delivers Quetiapine in a prolonged-release manner, ensuring a steady concentration of the medication in the blood over an extended period. This feature reduces the frequency of dosing and enhances treatment adherence.\nAntipsychotic and Mood-Stabilizing Actions:\nQuetiapine, the active ingredient in QT-PINE SR 200, acts by blocking dopamine and serotonin receptors in the brain, effectively reducing psychotic symptoms such as hallucinations and delusions in schizophrenia and bipolar disorder. It also helps stabilize mood swings in bipolar disorder, preventing manic and depressive episodes.\nAntidepressant Effects:\nQT-PINE SR 200 is prescribed for MDD, where it functions as an antidepressant by modulating serotonin and norepinephrine levels, alleviating depressive symptoms and improving overall well-being.\nAnxiolytic Properties:\nQuetiapine's anxiolytic properties contribute to its efficacy in managing anxiety disorders, including generalized anxiety disorder (GAD) and social anxiety disorder (SAD).\nDosage and Administration:\nInitial Dosage: The typical starting dose of QT-PINE SR 200 is 200mg taken orally once daily, usually in the evening due to its sedative effects. Dosage adjustments may be made by your healthcare provider based on individual response and tolerability.\nAdministration: Swallow the QT-PINE SR 200 tablet whole with water, without crushing or chewing it. Follow the prescribed dosing schedule strictly to maintain therapeutic blood levels.\nDuration of Treatment: Continue taking QT-PINE SR 200 as directed by your doctor, even if symptoms improve. Abruptly stopping the medication can lead to relapse or withdrawal symptoms.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW.\n", "price": 116.0, "discountamount": 35.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "MDD", "GAD", "SAD", "manic", "brain", "200mg", "EMAIL", "water", "doctor", "evening", "product", "relapse", "Duration", "efficacy", "Benefits", "dopamine", "frequency", "delusions", "medication", "qt-pine-sr", "mood swings", "information", "individuals", "sterispharma", "tolerability", "Key Features", "sterisonline", "Introduction", "CALL/WHATSAPP", "schizophrenia", "hallucinations", "Administration", "Initial Dosage", "release manner", "extended period", "bipolar disorder", "sedative effects", "anxiety disorders", "active ingredient", "overall well-being", "psychotic symptoms", "Dosage adjustments", "individual response", "depressive symptoms", "serotonin receptors", "depressive episodes", "healthcare provider", "treatment adherence", "withdrawal symptoms", "steady concentration", "QT-PINE SR 200 tablet", "Anxiolytic Properties", "norepinephrine levels", "psychiatric disorders", "typical starting dose", "atypical antipsychotic", "Antidepressant Effects", "social anxiety disorder", "therapeutic blood levels", "Mood Stabilizing Actions", "major depressive disorder", "prescribed dosing schedule", "Quetiapine Prolonged Release", "Extended Release Formulation", "generalized anxiety disorder", "other psychiatric conditions", "prolonged-release formulation", "sustained therapeutic effects" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1883, "imageuri": "https://productimages.withfloats.com/actual/666ae1184b514c761a318679.jpg", "tileimageuri": "https://productimages.withfloats.com/tile/666ae1184b514c761a318679.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-13T12:07:49.791Z", "updatedon": "2026-03-12T11:24:48.296Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//qt-pine-sr-200-/1883", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "QT-PINE SR 200 ", "category": "NEUROLOGY RANGE", "tags": [ "qutipin 200 uses", "quetiapine for sleep reviews", "qutipin 200 mg side effects", "quetiapine reviews for depression", "prolonged-release formulation." ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "666adf6d8999680f1480a619", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Propranolol SR 40mg ", "description": "PROPENOL SR 40 \nPropranolol SR (40mg)\nIntroduction:\nPROPENOL SR 40 is an extended-release formulation of Propranolol, a beta-blocker widely used for managing various cardiovascular conditions. This medication offers sustained therapeutic effects, reducing the frequency of dosing and providing continuous cardiovascular support.\nPROPENOL SR 40: Extended-Release Propranolol for Cardiovascular Health\n\nIntroduction:\nPROPENOL SR 40 is an extended-release formulation of Propranolol, a beta-blocker widely used for managing various cardiovascular conditions. This medication offers sustained therapeutic effects, reducing the frequency of dosing and providing continuous cardiovascular support.\n\nKey Features and Benefits:\nExtended-Release Formulation:\nPROPENOL SR 40 delivers Propranolol in a sustained manner, maintaining therapeutic levels in the bloodstream over an extended period.\nThis extended-release feature allows for once-daily dosing, improving patient compliance and convenience.\nCardiovascular Benefits:\n\nHypertension Management: Propranolol, a non-selective beta-blocker, effectively lowers blood pressure by blocking beta-adrenergic receptors, reducing heart rate and cardiac output.\nAngina Relief: It also helps manage angina pectoris by decreasing myocardial oxygen demand and improving exercise tolerance.\nAnxiety and Performance Management:\n\nPropranolol is beneficial in alleviating symptoms of anxiety, performance anxiety, and stage fright by blocking the effects of adrenaline, leading to a calmer physiological response.\nMigraine Prevention:\n\nPROPENOL SR 40 is also indicated for migraine prophylaxis, reducing the frequency and severity of migraine attacks by stabilizing blood vessels and modulating neurotransmitter release.\nDosage and Administration:\n\nRecommended Dosage: The typical starting dose of PROPENOL SR 40 for hypertension is 80mg once daily, which may be adjusted based on individual response.\nAdministration: Take PROPENOL SR 40 orally with water, preferably at the same time each day. Swallow the extended-release capsules whole without crushing or chewing.\nMonitoring: Regular monitoring of blood pressure and heart rate is essential during treatment to assess therapeutic response and adjust dosage if necessary.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\nhttps://www.sterisonline.com/product/propenol-sr-40-134109", "price": 49.0, "discountamount": 14.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "80mg", "Order", "EMAIL", "water", "product", "severity", "symptoms", "same time", "frequency", "treatment", "heart rate", "medication", "adrenaline", "propenol-sr", "bloodstream", "PROPENOL SR", "information", "convenience", "Key Features", "sterispharma", "Introduction", "daily dosing", "sterisonline", "stage fright", "CALL/WHATSAPP", "blood vessels", "Angina Relief", "blood pressure", "Administration", "Propranolol SR", "cardiac output", "angina pectoris", "extended period", "sustained manner", "migraine attacks", "therapeutic levels", "patient compliance", "Recommended Dosage", "exercise tolerance", "Regular monitoring", "Migraine Prevention", "individual response", "performance anxiety", "therapeutic response", "migraine prophylaxis", "typical starting dose", "Cardiovascular Health", "selective beta-blocker", "Performance Management", "Hypertension Management", "Cardiovascular Benefits", "neurotransmitter release", "extended-release feature", "myocardial oxygen demand", "extended-release capsules", "beta-adrenergic receptors", "Extended-Release Propranolol", "extended-release formulation", "sustained therapeutic effects", "calmer physiological response", "continuous cardiovascular support", "various cardiovascular conditions" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1881, "imageuri": "https://productimages.withfloats.com/actual/666adf70ae2cbfae74d23ceb.png", "tileimageuri": "https://productimages.withfloats.com/tile/666adf70ae2cbfae74d23ceb.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-13T12:00:45.598Z", "updatedon": "2026-03-13T06:43:11.809Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//propranolol-sr-40mg-/1881", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "PROPENOL SR 40 ", "category": "NEUROLOGY RANGE", "tags": [ "PROPENOL SR 40", "Propranolol SR (40mg)", "PROPENOL SR 40 mg", "Provanol SR 40 side effects", "Provanol SR 40 uses", "Provanol SR 40 dosage" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "66642e4866170d1ff8cb6484", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Levosulpiride sustained release 75mg", "description": "LT PRIDE OD 75\nLevosulpiride sustained release (75mg)\nLT Pride OD 75 is a medication that contains Levosulpiride sustained release (75mg). Levosulpiride is a dopamine receptor antagonist that is used to treat various gastrointestinal and psychiatric disorders. Here are some key points about LT Pride OD 75:\n\nIndications: Levosulpiride is primarily prescribed for conditions such as gastroesophageal reflux disease (GERD), functional dyspepsia, and irritable bowel syndrome (IBS). It helps in relieving symptoms like nausea, vomiting, bloating, and abdominal discomfort.\n\nPsychiatric Uses: In psychiatric practice, Levosulpiride is used to manage certain mood disorders such as depression, anxiety, and dysthymia. It works by modulating dopamine levels in the brain, which can have an impact on mood regulation.\n\nSustained Release Formulation: LT Pride OD 75 is a sustained release formulation, which means that the medication is released gradually over time, providing a more consistent and prolonged effect compared to immediate-release formulations.\n\nDosage: The typical dosage of LT Pride OD 75 is usually determined by the treating healthcare provider based on the patient's condition, age, and other factors. It is important to follow the prescribed dosage and administration instructions carefully.\n\nSide Effects: Common side effects of Levosulpiride may include drowsiness, dizziness, dry mouth, constipation, and changes in appetite. Serious side effects are rare but may include extrapyramidal symptoms (movement disorders), especially at higher doses.\n\nPrecautions: LT Pride OD 75 should be used with caution in patients with a history of neurological disorders, as it may exacerbate certain symptoms. It is not recommended for use in children without proper medical supervision.\n\nConsultation: Patients should consult their healthcare provider before starting or stopping LT Pride OD 75, especially if they are taking other medications or have any underlying medical conditions.\n\nLT Pride OD 75 with Levosulpiride sustained release (75mg) can be an effective treatment option for gastrointestinal and psychiatric disorders when used under medical guidance and supervision.\nFor further information:\nEmail: info@sterispharma.com / contact@sterispharma.com\nORDER Now: \n\n\n\n\n\n\n", "price": 115.0, "discountamount": 35.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "IBS", "Call", "time", "75mg", "GERD", "Email", "brain", "impact", "nausea", "history", "patient", "changes", "anxiety", "WhatsApp", "appetite", "bloating", "children", "vomiting", "dizziness", "dysthymia", "dry mouth", "consistent", "key points", "drowsiness", "depression", "Indications", "Precautions", "information", "LT PRIDE OD", "Consultation", "sterisonline", "sterispharma", "constipation", "higher doses", "other factors", "typical dosage", "mood disorders", "mood regulation", "dopamine levels", "medical guidance", "prolonged effect", "Psychiatric Uses", "other medications", "movement disorders", "Common side effects", "healthcare provider", "abdominal discomfort", "Serious side effects", "psychiatric practice", "functional dyspepsia", "psychiatric disorders", "neurological disorders", "extrapyramidal symptoms", "various gastrointestinal", "irritable bowel syndrome", "proper medical supervision", "effective treatment option", "administration instructions", "dopamine receptor antagonist", "underlying medical conditions", "Sustained Release Formulation", "immediate-release formulations", "Levosulpiride sustained release", "gastroesophageal reflux disease" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1571, "imageuri": "https://productimages.withfloats.com/actual/66642e4bcb17fd7b0aaa1c54.png", "tileimageuri": "https://productimages.withfloats.com/tile/66642e4bcb17fd7b0aaa1c54.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-08T10:11:20.585Z", "updatedon": "2026-03-12T07:12:34.55Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//levosulpiride-sustained-release-75mg/1571", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "LT PRIDE OD 75", "category": "GASTROLOGYRANGE", "tags": [ "LT PRIDE OD 75", "Levosulpiride sustained release (75mg)", "Levosulpiride 25 mg Tablet uses", "Levosulpiride before or after food", "Levosulpiride side effects", "Levosulpiride capsule uses", "Levosulpiride 25mg" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "6662b5587de2b5203089e01d", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "VILDIABATE M 850 ", "description": "VILDIABATE M 850 \nMetformin (850mg)SR, Vildagliptin (50mg)\nIntroduction to VILDIABATE M 850\nVILDIABATE M 850 is a combination medication designed to manage type 2 diabetes mellitus effectively. It combines Metformin Hydrochloride Sustained Release (SR) 850mg and Vildagliptin 50mg. This dual-action formulation targets different pathways involved in glucose regulation, providing comprehensive blood sugar control. It is used alongside diet and exercise to improve glycemic control in adults with type 2 diabetes.\n\nKey Components and Their Mechanisms\nMetformin SR 850mg\nMetformin is a biguanide that helps lower blood sugar levels through several mechanisms:\n\nReduces Hepatic Glucose Production: Metformin decreases the amount of glucose produced by the liver.\nImproves Insulin Sensitivity: It enhances the sensitivity of muscle cells to insulin, promoting better glucose uptake and utilization.\nDecreases Intestinal Absorption of Glucose: Metformin reduces the absorption of glucose from the gastrointestinal tract.\nThe sustained-release (SR) formulation ensures a gradual release of the medication, providing prolonged therapeutic effects and reducing the risk of gastrointestinal side effects.\n\nVildagliptin 50mg\nVildagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor that works by:\n\nEnhancing Incretin Levels: Vildagliptin inhibits the DPP-4 enzyme, which degrades incretin hormones such as GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic peptide). These hormones increase insulin secretion and decrease glucagon release in a glucose-dependent manner.\nImproving Postprandial Glucose Control: By enhancing the action of incretin hormones, Vildagliptin helps regulate blood sugar levels after meals.\nBenefits of VILDIABATE M 850\nComprehensive Blood Sugar Control\nFasting and Postprandial Glucose Management: The combination of Metformin SR and Vildagliptin effectively manages both fasting and postprandial (after-meal) blood sugar levels.\nImproved Insulin Sensitivity and Secretion: Metformin improves insulin sensitivity, while Vildagliptin enhances insulin secretion in response to meals.\nExtended Release Formulation\nProlonged Effect: The sustained-release formulation of Metformin ensures a steady release of the medication, providing long-lasting blood sugar control and minimizing peaks and troughs in blood sugar levels.\nReduced Gastrointestinal Side Effects: The gradual release of Metformin helps reduce common gastrointestinal side effects associated with immediate-release formulations.\nAdditional Health Benefits\nLow Risk of Hypoglycemia: Vildagliptin has a low risk of causing hypoglycemia (low blood sugar) because it enhances insulin secretion only when blood glucose levels are elevated.\nWeight Neutral: This combination is generally weight-neutral, making it a suitable option for patients concerned about weight gain.\nDosage and Administration\nRecommended Dosage\nDosage: The typical dosage is one tablet taken once or twice daily, preferably with a meal to reduce gastrointestinal side effects.\nAdministration: Swallow the tablet whole with a glass of water. Do not crush, chew, or split the tablet unless advised by your healthcare provider.\nGuidelines for Optimal Use\nConsistent Use: For best results, take VILDIABATE M 850 regularly at the same time each day as prescribed by your healthcare provider.\nMonitor Blood Sugar Levels: Regular monitoring of blood sugar levels is essential to ensure the medication is effectively controlling your diabetes. Adjustments to your treatment plan may be necessary based on these readings.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/vildiabate-m-850-133455", "price": 299.0, "discountamount": 89.7, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "GIP", "diet", "Order", "EMAIL", "water", "glass", "liver", "GLP-1", "peaks", "meals", "adults", "amount", "option", "troughs", "Fasting", "exercise", "Low Risk", "patients", "readings", "response", "Enhancing", "same time", "biguanide", "Guidelines", "one tablet", "weight gain", "Optimal Use", "information", "Adjustments", "utilization", "Vildagliptin", "Metformin SR", "sterispharma", "Hypoglycemia", "Introduction", "best results", "sterisonline", "DPP-4 enzyme", "muscle cells", "CALL/WHATSAPP", "treatment plan", "glucose uptake", "steady release", "typical dosage", "Key Components", "Administration", "Weight Neutral", "Consistent Use", "low blood sugar", "Incretin Levels", "gradual release", "glycemic control", "VILDIABATE M 850", "glucagon release", "Prolonged Effect", "DPP-4) inhibitor", "incretin hormones", "insulin secretion", "glucose regulation", "several mechanisms", "different pathways", "Regular monitoring", "healthcare provider", "Insulin Sensitivity", "blood glucose levels", "Intestinal Absorption", "combination medication", "dipeptidyl peptidase-4", "gastrointestinal tract", "dual-action formulation", "meal) blood sugar levels", "type 2 diabetes mellitus", "glucose-dependent manner", "Recommended Dosage Dosage", "Additional Health Benefits", "Hepatic Glucose Production", "Extended Release Formulation", "sustained-release formulation", "prolonged therapeutic effects", "immediate-release formulations", "Postprandial Glucose Management", "long-lasting blood sugar control", "comprehensive blood sugar control", "sustained-release (SR) formulation", "common gastrointestinal side effects", "Reduced Gastrointestinal Side Effects", "Improving Postprandial Glucose Control", "glucose-dependent insulinotropic peptide", "Metformin Hydrochloride Sustained Release" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1504, "imageuri": "https://productimages.withfloats.com/actual/667d44a2576e8da931df856b.png", "tileimageuri": "https://productimages.withfloats.com/tile/667d44a2576e8da931df856b.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-07T07:23:04.367Z", "updatedon": "2026-03-14T06:50:04.324Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//vildiabate-m-850-/1504", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "VILDIABATE M 850 ", "category": "DIABETIC RANGE", "tags": [ "vildagliptin metformin 50/850 price", "vildagliptin and metformin hydrochloride tablets s" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "6662b1e6870e7b20c49e6522", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "VILDIABATE M 500 ", "description": "VILDIABATE M 500 \nMetformin (500mg)SR, Vildagliptin (50mg)\nIntroduction to VILDIABATE M 500\nVILDIABATE M 500 is a combination medication designed to manage type 2 diabetes mellitus effectively. It contains Metformin Hydrochloride Sustained Release (SR) 500mg and Vildagliptin 50mg. This dual-action formula targets different pathways involved in glucose regulation to provide comprehensive blood sugar control. It is used alongside diet and exercise to improve glycemic control in adults with type 2 diabetes.\n\nKey Components and Their Mechanisms\nMetformin SR 500mg\nMetformin is a biguanide that helps lower blood sugar levels through several mechanisms:\n\nReduces Hepatic Glucose Production: Metformin decreases the amount of glucose produced by the liver.\nImproves Insulin Sensitivity: It enhances the sensitivity of muscle cells to insulin, promoting better glucose uptake and utilization.\nDecreases Intestinal Absorption of Glucose: Metformin reduces the absorption of glucose from the gastrointestinal tract.\nThe sustained-release (SR) formulation ensures a gradual release of the medication, providing prolonged therapeutic effects and reducing the risk of gastrointestinal side effects.\n\nVildagliptin 50mg\nVildagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor that works by:\n\nEnhancing Incretin Levels: Vildagliptin inhibits the DPP-4 enzyme, which degrades incretin hormones such as GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic peptide). These hormones increase insulin secretion and decrease glucagon release in a glucose-dependent manner.\nImproving Postprandial Glucose Control: By enhancing the action of incretin hormones, Vildagliptin helps regulate blood sugar levels after meals.\nBenefits of VILDIABATE M 500\nComprehensive Blood Sugar Control\nFasting and Postprandial Glucose Management: The combination of Metformin SR and Vildagliptin effectively manages both fasting and postprandial (after-meal) blood sugar levels.\nImproved Insulin Sensitivity and Secretion: Metformin improves insulin sensitivity, while Vildagliptin enhances insulin secretion in response to meals.\nExtended Release Formulation\nProlonged Effect: The sustained-release formulation of Metformin ensures a steady release of the medication, providing long-lasting blood sugar control and minimizing peaks and troughs in blood sugar levels.\nReduced Gastrointestinal Side Effects: The gradual release of Metformin helps reduce common gastrointestinal side effects associated with immediate-release formulations.\nAdditional Health Benefits\nLow Risk of Hypoglycemia: Vildagliptin has a low risk of causing hypoglycemia (low blood sugar) because it enhances insulin secretion only when blood glucose levels are elevated.\nWeight Neutral: This combination is generally weight-neutral, making it a suitable option for patients concerned about weight gain.\nDosage and Administration\nRecommended Dosage\nDosage: The typical dosage is one tablet taken once or twice daily, preferably with a meal to reduce gastrointestinal side effects.\nAdministration: Swallow the tablet whole with a glass of water. Do not crush, chew, or split the tablet unless advised by your healthcare provider.\nGuidelines for Optimal Use\nConsistent Use: For best results, take VILDIABATE M 500 regularly at the same time each day as prescribed by your healthcare provider.\nMonitor Blood Sugar Levels: Regular monitoring of blood sugar levels is essential to ensure the medication is effectively controlling your diabetes. Adjustments to your treatment plan may be necessary based on these readings.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/vildiabate-m-500-133454", "price": 289.0, "discountamount": 86.7, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "GIP", "diet", "Order", "EMAIL", "water", "glass", "liver", "GLP-1", "peaks", "meals", "adults", "amount", "option", "troughs", "Fasting", "exercise", "Low Risk", "patients", "readings", "response", "Enhancing", "same time", "biguanide", "Guidelines", "one tablet", "weight gain", "Optimal Use", "information", "Adjustments", "utilization", "Vildagliptin", "Metformin SR", "sterispharma", "Hypoglycemia", "Introduction", "best results", "sterisonline", "DPP-4 enzyme", "muscle cells", "CALL/WHATSAPP", "glucose uptake", "steady release", "typical dosage", "Key Components", "treatment plan", "Weight Neutral", "Consistent Use", "Administration", "Incretin Levels", "gradual release", "low blood sugar", "glycemic control", "DPP-4) inhibitor", "VILDIABATE M 500", "glucagon release", "Prolonged Effect", "incretin hormones", "insulin secretion", "several mechanisms", "different pathways", "Regular monitoring", "glucose regulation", "dual-action formula", "Insulin Sensitivity", "healthcare provider", "blood glucose levels", "Intestinal Absorption", "combination medication", "gastrointestinal tract", "dipeptidyl peptidase-4", "type 2 diabetes mellitus", "glucose-dependent manner", "meal) blood sugar levels", "Recommended Dosage Dosage", "Additional Health Benefits", "Hepatic Glucose Production", "Extended Release Formulation", "sustained-release formulation", "prolonged therapeutic effects", "immediate-release formulations", "Postprandial Glucose Management", "long-lasting blood sugar control", "comprehensive blood sugar control", "sustained-release (SR) formulation", "common gastrointestinal side effects", "Reduced Gastrointestinal Side Effects", "Improving Postprandial Glucose Control", "glucose-dependent insulinotropic peptide", "Metformin Hydrochloride Sustained Release" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1499, "imageuri": "https://productimages.withfloats.com/actual/667d4af8b567218985111efd.png", "tileimageuri": "https://productimages.withfloats.com/tile/667d4af8b567218985111efd.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-07T07:08:22.623Z", "updatedon": "2026-03-13T06:47:01.072Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//vildiabate-m-500-/1499", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "VILDIABATE M 500 ", "category": "DIABETIC RANGE", "tags": [ "vildagliptin metformin 50/1000", "vildagliptin metformin 50/500 price", "ildagliptin and metformin hydrochloride tablets si" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "6662af26db100e1fdc2dcc17", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "VILDIABATE M 1000 ", "description": "VILDIABATE M 1000 \nMetformin (1000mg)SR, Vildagliptin (50mg)\nIntroduction to VILDIABATE M 1000\nVILDIABATE M 1000 is a combination medication designed for the effective management of type 2 diabetes mellitus. It contains Metformin Hydrochloride Sustained Release (SR) 1000mg and Vildagliptin 50mg. This dual-action formula targets different pathways involved in glucose regulation to provide comprehensive blood sugar control. It is used alongside diet and exercise to improve glycemic control in adults with type 2 diabetes.\n\nKey Components and Their Mechanisms\nMetformin SR 1000mg\nMetformin is a biguanide that helps lower blood sugar levels through several mechanisms:\n\nReduces Hepatic Glucose Production: Metformin decreases the amount of glucose produced by the liver.\nImproves Insulin Sensitivity: It enhances the sensitivity of muscle cells to insulin, promoting better glucose uptake and utilization.\nDecreases Intestinal Absorption of Glucose: Metformin reduces the absorption of glucose from the gastrointestinal tract.\nThe sustained release (SR) formulation ensures a gradual release of the medication, providing prolonged therapeutic effects and reducing the risk of gastrointestinal side effects.\n\nVildagliptin 50mg\nVildagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor that works by:\n\nEnhancing Incretin Levels: Vildagliptin inhibits the DPP-4 enzyme, which degrades incretin hormones such as GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic peptide). These hormones increase insulin secretion and decrease glucagon release in a glucose-dependent manner.\nImproving Postprandial Glucose Control: By enhancing the action of incretin hormones, Vildagliptin helps regulate blood sugar levels after meals.\nBenefits of VILDIABATE M 1000\nComprehensive Blood Sugar Control\nFasting and Postprandial Glucose Management: The combination of Metformin SR and Vildagliptin effectively manages both fasting and postprandial (after-meal) blood sugar levels.\nImproved Insulin Sensitivity and Secretion: Metformin improves insulin sensitivity, while Vildagliptin enhances insulin secretion in response to meals.\nExtended Release Formulation\nProlonged Effect: The sustained-release formulation of Metformin ensures a steady release of the medication, providing long-lasting blood sugar control and minimizing peaks and troughs in blood sugar levels.\nReduced Gastrointestinal Side Effects: The gradual release of Metformin helps reduce common gastrointestinal side effects associated with immediate-release formulations.\nAdditional Health Benefits\nLow Risk of Hypoglycemia: Vildagliptin, in particular, has a low risk of causing hypoglycemia (low blood sugar) because it enhances insulin secretion only when blood glucose levels are elevated.\nWeight Neutral: This combination is generally weight neutral, making it a suitable option for patients concerned about weight gain.\nDosage and Administration\nRecommended Dosage\nDosage: The typical dosage is one tablet taken once daily, preferably with a meal to reduce gastrointestinal side effects.\nAdministration: Swallow the tablet whole with a glass of water. Do not crush, chew, or split the tablet unless advised by your healthcare provider.\nGuidelines for Optimal Use\nConsistent Use: For best results, take VILDIABATE M 1000 regularly at the same time each day as prescribed by your healthcare provider.\nMonitor Blood Sugar Levels: Regular monitoring of blood sugar levels is essential to ensure the medication is effectively controlling your diabetes. Adjustments to your treatment plan may be necessary based on these readings.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/vildiabate-m-1000-133453", "price": 319.0, "discountamount": 95.7, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "GIP", "diet", "GLP-1", "Order", "EMAIL", "water", "glass", "liver", "peaks", "meals", "adults", "amount", "option", "troughs", "Fasting", "exercise", "Low Risk", "patients", "response", "readings", "same time", "Enhancing", "biguanide", "one tablet", "Guidelines", "Optimal Use", "information", "utilization", "weight gain", "Adjustments", "Introduction", "Vildagliptin", "Metformin SR", "VILDIABATE M", "sterispharma", "best results", "Hypoglycemia", "sterisonline", "DPP-4 enzyme", "muscle cells", "CALL/WHATSAPP", "Weight Neutral", "Consistent Use", "Administration", "treatment plan", "steady release", "typical dosage", "Key Components", "glucose uptake", "low blood sugar", "Incretin Levels", "gradual release", "SR) formulation", "glucagon release", "glycemic control", "Prolonged Effect", "DPP-4) inhibitor", "insulin secretion", "incretin hormones", "several mechanisms", "different pathways", "glucose regulation", "Regular monitoring", "dual-action formula", "healthcare provider", "Insulin Sensitivity", "blood glucose levels", "effective management", "Intestinal Absorption", "gastrointestinal tract", "combination medication", "dipeptidyl peptidase-4", "type 2 diabetes mellitus", "glucose-dependent manner", "meal) blood sugar levels", "Recommended Dosage Dosage", "Additional Health Benefits", "Hepatic Glucose Production", "Extended Release Formulation", "sustained-release formulation", "prolonged therapeutic effects", "immediate-release formulations", "Postprandial Glucose Management", "long-lasting blood sugar control", "comprehensive blood sugar control", "common gastrointestinal side effects", "Reduced Gastrointestinal Side Effects", "Improving Postprandial Glucose Control", "glucose-dependent insulinotropic peptide", "Metformin Hydrochloride Sustained Release" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1496, "imageuri": "https://productimages.withfloats.com/actual/6662af29d878d473a9fda03d.png", "tileimageuri": "https://productimages.withfloats.com/tile/6662af29d878d473a9fda03d.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-07T06:56:38.67Z", "updatedon": "2026-03-13T06:46:17.898Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//vildiabate-m-1000-/1496", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "VILDIABATE M 1000 ", "category": "DIABETIC RANGE", "tags": [ "VILDIABATE M 1000", "Metformin (1000mg)SR", "Vildagliptin (50mg)", "Vildagliptin 50mg side effects", "Vildagliptin tablets 50 mg uses", "Vildagliptin 50 mg price", "Vildagliptin 50 mg and metformin 500 mg" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false } ], "hasmoreitems": false, "isapirequest": false, "totalresults": 27, "query": null, "floatingpoint": null }